That's Gazyva in SLE, [indiscernible], the fenebrutinib data in PPMS. For several Phase II assets ... privilege is lost and there's inflammation in the eye and many different structures in the eye can ...
On today's call, we will provide details on our third quarter performance as outlined in the morning's press release. On the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback